Resultats de la cerca - Von, Thanh
- Mostrar 1 - 12 resultats de 12
-
1
-
2
-
3
Spatially distinct roles of class Ia PI3K isoforms in the development and maintenance of PTEN hamartoma tumor syndrome per Wang, Qi, Von, Thanh, Bronson, Roderick, Ruan, Minzi, Mu, Wenxia, Huang, Alan, Maira, Sauveur-Michel, Zhao, Jean J.
Publicat 2013Text -
4
NTRK2 activation cooperates with PTEN deficiency in T-ALL through activation of both the PI3K–AKT and JAK–STAT3 pathways per Yuzugullu, Haluk, Von, Thanh, Thorpe, Lauren M, Walker, Sarah R, Roberts, Thomas M, Frank, David A, Zhao, Jean J
Publicat 2016Text -
5
PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers per Wang, Qi, Liu, Pian, Spangle, Jennifer M., Von, Thanh, Roberts, Thomas M., Lin, Nancy U., Krop, Ian E., Winer, Eric P., Zhao, Jean J.
Publicat 2015Text -
6
Functional characterization of an isoform-selective inhibitor of PI3K-p110β as a potential anti-cancer agent per Ni, Jing, Liu, Qingsong, Xie, Shaozhen, Carlson, Coby B., Von, Thanh, Vogel, Kurt W., Riddle, Steve M., Benes, Cyril H., Eck, Michael J., Roberts, Thomas M, Gray, Nathanael S., Zhao, Jean J.
Publicat 2012Text -
7
Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α per Gritsman, Kira, Yuzugullu, Haluk, Von, Thanh, Yan, Howard, Clayton, Linda, Fritsch, Christine, Maira, Sauveur-Michel, Hollingworth, Gregory, Choi, Christine, Khandan, Tulasi, Paktinat, Mahnaz, Okabe, Rachel O., Roberts, Thomas M., Zhao, Jean J.
Publicat 2014Text -
8
MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells per Wang, Yubao, Lee, Young-Mi, Baitsch, Lukas, Huang, Alan, Xiang, Yi, Tong, Haoxuan, Lako, Ana, Von, Thanh, Choi, Christine, Lim, Elgene, Min, Junxia, Li, Li, Stegmeier, Frank, Schlegel, Robert, Eck, Michael J, Gray, Nathanael S, Mitchison, Timothy J, Zhao, Jean J
Publicat 2014Text -
9
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer per Wang, Yubao, Zhang, Tinghu, Kwiatkowski, Nicholas, Abraham, Brian J., Lee, Tong Ihn, Xie, Shaozhen, Yuzugullu, Haluk, Von, Thanh, Li, Heyuan, Lin, Ziao, Stover, Daniel G., Lim, Elgene, Wang, Zhigang C., Iglehart, J. Dirk, Young, Richard A., Gray, Nathanael S., Zhao, Jean J.
Publicat 2015Text -
10
Correction: MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells per Wang, Yubao, Li, Young-Mi, Baitsch, Lukas, Huang, Alan, Xiang, Yi, Tong, Haoxuan, Lako, Ana, Von, Thanh, Choi, Christine, Lim, Elgene, Min, Junxia, Li, Li, Stegmeier, Frank, Schlegel, Robert, Eck, Michael J, Gray, Nathanael S, Mitchison, Timothy J, Zhao, Jean J
Publicat 2018Text -
11
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation per Li, Andrew G., Murphy, Elizabeth C., Culhane, Aedin C., Powell, Emily, Wang, Hua, Bronson, Roderick T., Von, Thanh, Giobbie-Hurder, Anita, Gelman, Rebecca S., Briggs, Kimberly J., Piwnica-Worms, Helen, Zhao, Jean J., Kung, Andrew L., Kaelin, William G., Livingston, David M.
Publicat 2018Text -
12
Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer per Gao, Xueliang, Wang, Yubao, Ribeiro, Caroline F., Manokaran, Cherubin, Chang, Hyeyoun, Von, Thanh, Rodrigues, Silvia, Cizmecioglu, Onur, Jia, Shidong, Korpal, Manav, Korn, Joshua M., Wang, Zhigang, Schmit, Fabienne, Jiang, Lan, Pagliarini, Raymond, Yang, Yi, Sethi, Isha, Signoretti, Sabina, Yuan, Guo-Cheng, Loda, Massimo, Zhao, Jean J., Roberts, Thomas M.
Publicat 2022Text